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ABSTRACT 
Purpose of review: Habitual physical activity can reduce the risk of future 
cardiovascular morbidity and mortality. This review evaluates recent publications that 
have assessed the impact of the dose of physical (in)activity on cardiovascular 
outcomes.    
Recent findings: Sedentary behavior, characterized by prolonged sitting, is 
increasingly prevalent across the globe and increases the risk for cardiovascular 
events in a dose-dependent fashion. Similarly, the number of individuals performing 
endurance exercise events has tripled over the last 2 decades, and some studies 
suggest that the high volumes of exercise training and competition may attenuate the 
health benefits of a physically active lifestyle.  
Summary: Breaking-up sitting time or replacing sitting by (light) physical activity are 
effective strategies to attenuate its detrimental health effects. Low doses of physical 
activity, preferably at a high-intensity, significantly reduce the risk for cardiovascular 
and all-cause mortality. Larger doses of exercise yield larger health benefits. Extreme 
doses of exercise neither increase nor decrease the risk for adverse outcomes. 
Athletes demonstrate a transient cardiac dysfunction and biomarker release directly 
post-exercise. Chronic exercise training may increase the risk for atrial fibrillation, but 
is also associated with a superior life expectancy compared to the general population.  
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INTRODUCTION  
Physical activity and the ability to perform endurance exercise played an essential role 
in human evolution [1]. Our early ancestors combined long-distance running and 
walking to track and hunt animals on the African savannah. During so-called 
‘persistence hunts’, distances >30 km were regularly covered [2]. In contrast to this 
intermittent but substantial exertion, it is believed that hunters were predominantly 
physically inactive during the remainder of the day [1]. This inactive behavior reduced 
their energy expenditure and was essential to maintain a proper balance between 
energy intake and expenditure.  
During the past century, our lifestyle has changed dramatically and the role of 
physical exertion is minimized in our contemporary lives. Machines have taken over 
the majority of our physical efforts at work, home and during transportation. 
Consequently, the prevalence of sitting time has increased, whereas the time 
performing exercise has decreased. These changes in habitual physical activity 
patterns greatly impact the energy intake/expenditure balance, which have contributed 
to an alarming increase in the incidence of obesity and other chronic diseases [3, 4]. 
Hence, physical inactivity was recently recognized as a major threat to global health 
[5]. 
The World Health Organization recommends that adults engage in at least 150 
min/week of moderate-intensity exercise or 75 min/week of vigorous-intensity exercise 
[6].  Currently, only 61% of the European population [7] and 44% of the North American 
population [8] perform sufficient physical activity to meet the WHO guidelines, 
percentages that have changed only slightly over the past 20 years [9]. Incongruously, 
an increasing number of amateur athletes are participating in endurance exercise 
events. In fact, the number of US running race participants has tripled over the past 
two decades [10]. Although exercise training is believed to improve cardiovascular 
health [11], recent studies suggest that excessive volumes of physical activity may 
harm the heart [12]. 
The purpose of this review is to provide an overview of recent insights relating 
to the risks and benefits of physical activity. Given the increased prevalence of physical 
inactivity and the increasing popularity of endurance exercise activities, we will 
summarize the cardiovascular risks and benefits across the physical activity 
continuum: from sitting behavior to extreme volumes of exercise.   
 
PHYSICAL INACTIVITY AND SITTING BEHAVIOR 
Physical activity is defined as any bodily movement produced by skeletal muscles that 
results in energy expenditure beyond resting expenditure. Hence, physical inactivity 
represents sedentary behavior that does not involve muscle contraction, which is most 
prevalent during sitting and lying. Recent studies revealed that accelerometer-
measured mean daily sedentary time was 8.2 hrs/day among New York City adults 
[13], whereas Australian desk workers reported an average of 9.0 hrs/day of sitting 
time [14]. Physical inactivity is not restricted to the general population; it can be 
observed in (half-)marathon runners as they have reported sitting 10.75 hrs/day on 
workdays and 8 hrs/day  on non-workdays [15].   
A recent meta-analysis combining the outcomes of 41 studies (n=829,917 
participants) found that sedentary time was associated with cardiovascular mortality 
(HR: 1.18, 95%CI: 1.11-1.26), but also with cardiovascular disease incidence (HR: 
1.14, 95%CI: 1.0011.73), cancer mortality (HR: 1.17, 95%CI: 1.11-1.24), cancer 
incidence (HR: 1.13, 95%CI 1.05-1.21), and the incidence of type 2 diabetes (HR: 1.91, 
95%CI: 1.64-2.22) [16]. The authors emphasized that the detrimental health effects of 
sitting were independent of the physical activity patterns of study participants [16]. The 
population-attributable fraction for all-cause mortality associated with sitting time was 
explored in another paper and included data from 54 countries. Sitting time was 
responsible for 3.8% of all-cause mortality, but large differences were observed across 
countries (0.6-11.6%) [17]. The sitting- related mortality risk was the highest in Western 
Pacific countries (5.7%), followed by European (4.4%), Eastern Mediterranean (3.3%), 
American (3.2%), and Southeast Asian (2.0%) countries [17]. 
A potential strategy to reduce the harmful effects of prolonged sitting, is to limit 
the duration of sitting sessions [18]. Breaking-up prolonged sitting time with 2 minute 
bouts of walking reduced postprandial glucose and insulin levels [19] and lowered 
systolic and diastolic blood pressure [20]. A different strategy is to replace sitting time 
with exercise or non-exercise activities (i.e. household chores, lawn and garden work, 
and daily walking). In a cross-sectional analysis, less active individuals (<2 hrs/day, 
n=69,606) demonstrated a reduced risk for cardiovascular mortality when 1 hr/day of 
sitting was replaced by exercise (HR: 0.47, 95%CI: 0.40-0.56) or non-exercise 
activities (HR: 0.64, 95%CI: 0.57-0.71) [21]. Active individuals (≥2 hrs/day, n=85,008) 
also demonstrated a reduced risk for cardiovascular mortality when 1 hr/day of sitting 
was replaced by exercise (HR: 0.84, 95%CI 0.78-0.90) but no benefit was observed 
for non-exercise activities (HR: 1.00, 95%CI: 0.96-1.04) [21].  
An observational study modeled the health benefits of replacing 2 hrs/day of 
sitting by standing or stepping. Sitting-to-standing reallocation was associated with 
lower levels of fasting glucose (~2%), total/HDL-cholesterol ratio (~6%), triglycerides 
(~11%), and a higher HDL-cholesterol (~0.06 mmol/L) [22]. Sitting-to-stepping 
reallocation was associated with a lower BMI (~11%) and waist circumference (~7.5 
cm), and lower levels of post-load glucose (~12%), triglycerides (~14%) and a higher 
HDL-cholesterol (~0.10 mmol/L) [22]. The benefits of low-intensity activities to reduce 
the detrimental effects of sitting were reinforced by a recent study in the UK Women’s 
Cohort Study (n=12,778) [23]. Sitting ≥7 hrs/day significantly increased the risk for all-
cause mortality compared to sitting <5 hrs/day. However, fidgeting behavior (small 
movements of hands and feet) appeared to modify the association between sitting time 
and all-cause mortality. The increased mortality risk associated with sitting was only 
observed in women reporting no fidgeting, whereas women reporting regular to 
frequent fidgeting demonstrated comparable mortality risks between high and low 
volumes of sitting [23].  
Importantly, these observations demonstrate that small changes in sitting 
behavior can improve (cardiovascular) health. Consequently, policy documents from 
the United Kingdom and Australia already include statements about sitting behavior 
[24, 25]. Experts from the United Kingdom recommend including specific guidelines on 
sedentary behavior in future physical activity guidelines [24]. In Australia, minimizing 
time spent in prolonged sitting and breaking up long periods of sitting as often as 
possible are already included in the national physical activity guidelines [25]. These 
initiatives are likely to contribute to increased awareness of the detrimental health 
effects of sitting. Indeed, the time spent in sedentary behavior has not increased in 
European adults over the past decade [26]. More importantly, the prevalence of 
prolonged sitting (7.5 hrs/day) decreased from 23.1% in 2002 to 17.8 in 2013 [26]. 
Further reductions in sitting times may be achieved via workplace interventions such 
as sit-stand desks, but high quality intervention trials are needed to provide evidence 
for the cost-effectiveness and health benefits of such interventions [27].  
 
THE OPTIMAL EXERCISE DOSE  
Exercise is associated with risk reductions in at least 26 different diseases, including 
the metabolic syndrome, polycystic ovarian syndrome, type 1 and 2 diabetes, cancer, 
musculo-skeletal disorders and psychiatric, neurological, cardiovascular, pulmonary 
and metabolic diseases [28]. Furthermore, physically active individuals have a lower 
risk for all-cause and cardiovascular mortality and morbidity compared to sedentary 
peers [29, 30]. 
 Several recent papers have explored the dose-response relationship between 
physical activity and adverse health outcomes [31-33]. A pooled analysis including 
661,137 men and women from 6 large prospective American and European population 
studies found a 20% risk reduction for all-cause mortality in individuals performing 
moderate-intensity physical activity <100 min/week during 14 years of follow-up [34]. 
Increasing volumes of physical activity gradually decreased the mortality risk. The 
maximal benefit of an active lifestyle was found at an exercise dose representing 3 to 
5 times the WHO physical activity recommendation (HR: 0.61, 95%CI: 0.59-0.62) [34]. 
Larger doses of exercise did not further decrease mortality risks, but did not increase 
it either. These findings align with a recent perspective document from the American 
College of Cardiology’s (ACC’s) Sports and Exercise Cardiology Leadership Council. 
They reported that the ‘optimal’ exercise dose to reduce the risk for cardiovascular 
events was established at 41 MET-hrs/week: i.e. 9.1 hrs/week of moderate-intensity 
exercise [35].  
Interestingly, the dose-response relationship appears to be different for 
moderate versus vigorous intensity activities. Whereas a progressive decrease in the 
risk for cardiovascular mortality is observed for increasing volumes of moderate 
intensity physical activity, no further risk reduction is observed beyond a vigorous 
intensity exercise dose of 1.3 hrs/week (11 MET-hrs/week) [35]. These findings were 
reinforced by an Australian prospective cohort study (n=204,542) that investigated the 
role of vigorous activities on all-cause mortality during 6.5 years of follow-up. 
Individuals performing <30% of their total exercise dose at a vigorous intensity had a 
significantly lower mortality risk (HR: 0.91, 95%CI 0.84-0.98) compared to the 
reference group that performed a similar exercise dose but refrained from vigorous 
activities [36]. Individuals reporting ≥30% of their exercise dose to be vigorous 
demonstrated a comparable mortality risk reduction (HR: 0.87, 95%CI: 0.81-0.93) [36]. 
Thus, low doses of vigorous intensity physical activities seem to be extremely efficient 
at reducing the risk for adverse (cardiovascular) events. 
Despite the undeniable health benefits of exercise, a substantial proportion of 
the population does not perform enough physical activity to derive a health benefit [37]. 
Therefore, novel strategies to improve active behavior are needed [38]. Activity 
trackers are available globally and these devices provide real-time quantification and 
insight into one’s activity pattern. Hence, these trackers can assist an individual in 
reaching activity goals and adopting a physically active lifestyle. A randomized clinical 
trial found an increase of 970 steps/day in individuals receiving a wireless activity 
tracker, regardless of their initial activity level [39]. Personalized encouragement, social 
competition and effective feedback loops are other key factors needed to pursue a 
behavioral change towards an active lifestyle [40]. The ‘setting’ to stimulate individuals 
to become physically active is important. A randomized clinical trial compared 3 
methods to frame financial incentives to increase physical activity among overweight 
and obese adults [41]. Participants were instructed to cover 7000 steps/day and were 
randomly allocated to a 1) control, 2) gain incentive ($1.40/day if goal was achieved), 
3) lottery incentive (daily eligibility for $1.40 if goal was achieved), or 4) loss incentive 
($42 allocated monthly upfront and $1.40/day was removed if goal was not achieved) 
study groups. Only the loss incentive group demonstrated a larger proportion (0.45, 
95%CI: 0.38-0.52) of participant-days achieving the 7000 steps/day goal compared to 
the control group (0.30, 95%CI: 0.22-0.37) [41]. These findings emphasize the difficulty 
in changing behavior, but also that a tailored intervention can increase activity patterns 
in a group at risk. Personalized exercise prescriptions are therefore warranted in the 
era of precision medicine.  
 
TOO MUCH EXERCISE? 
The volume of exercise performed during training and competition by amateur and 
professional athletes to improve cardiorespiratory fitness often exceeds the dose 
needed to optimize cardiovascular health. High volumes of exercise training improve 
cardiovascular risk factors [42], and cause an initial increase in left ventricular chamber 
size followed by an increase in wall thickness during chronic exercise training [43]. 
Remodeling also occurs in the right heart, allowing the right ventricle to tolerate the 
increased pulmonary artery pressures during exercise [44]. These adaptations are part 
of the ‘athlete’s heart’ and are believed to represent physiological remodeling.  
Some studies suggest that performance of prolonged vigorous exercise (such 
as marathon running) may harm the heart acutely or chronically. For example, cardiac 
dysfunction of the left and right ventricles was observed immediately post-exercise in 
endurance athletes [45, 46]. Similarly, increased cardiac troponin levels have been 
reported following marathon running, with 69% of the population exceeding the upper 
limit of the normal threshold [47]. Both phenomena are transient, however, as cardiac 
function and biomarker levels typically recover within 24-48 hours post exercise [12]. 
The risk for acute adverse cardiac events during endurance exercise is therefore 
considered low, and data from a French registry demonstrated a prevalence of life 
threatening events of only 0.75 per 100 000 athletes [48].  
Cardiac remodeling associated with chronic exercise exposure may also 
increase the risk for arrhythmias in athletes [49]. A previous athletic population study 
[50] and a systematic review [51] have demonstrated an increased risk for atrial 
fibrillation (AF) in endurance athletes. However, contrasting findings were reported in 
2 recent studies. Data from the Henry Ford Exercise Testing (FIT) Project found a 7% 
risk reduction for AF with every increase of 1 MET in cardiorespiratory fitness [52]. Fit 
individuals had a substantially lower risk (HR: 0.44, 95%CI: 0.39-0.50) for incident AF 
compared to unfit individuals [52]. Similarly, data from the CARDIO-FIT Study found a 
20% reduction in the risk of AF recurrence for each MET increase in cardiorespiratory 
fitness among overweight and obese individuals with symptomatic AF [53]. Differences 
in maximum exercise capacity and cardiorespiratory fitness between the FIT/CARDIO-
FIT studies and previous observations in athletes may explain the conflicting outcomes 
[54]. It may well be that initial increases in cardiorespiratory fitness decrease the risk 
for AF, but that excessive exercise training and associated fitness increase the AF risk.    
 Finally, recent epidemiological studies have assessed the long-term outcomes 
of high volumes of exercise training. Data from the Million Women Study [55] and 
Copenhagen City Heart study [56] report a U-shaped curve for the relationship 
between exercise exposure and risk for morbidity and mortality. Thus, inactive 
individuals had the highest risks and physically active individuals demonstrated a 
reduced risk, but the benefits of exercise were attenuated in vigorous exercisers. 
These observations contradict pooled data from 6 European and American cohorts 
that noted that individuals performing exercise at a dose 5 – 10 times the international 
recommendations, had a 31% reduction in all-cause mortality risk (HR=0.69, 95%CI 
0.59-0.78) compared to inactive peers [34]. Furthermore, a 50-year follow-up study 
among Finnish elite athletes demonstrated that endurance athletes (HR: 0.70, 95%CI: 
0.61-0.79) and team sport athletes (HR: 0.80, 95%CI: 0.72-0.89) had lower mortality 
risks compared to controls [57]. Explanations for the different outcomes in the Million 
Women Study and Copenhagen City Heart study may relate to the characteristics of 
the most active individuals (high smoking prevalence and low socioeconomic status 
[31]) and definition of the control group (allowed to exercise <2h/week [58]). Therefore, 
we believe that there is currently no solid evidence for an increased risk for adverse 
outcomes in the most active individuals.  
 
CONCLUSIONS 
The priority for reducing cardiovascular burden should be mainly focused on the lower 
end of the physical activity continuum.  Physical inactivity, characterized by too much 
sitting, is a serious health problem as it independently increases the risk for 
cardiovascular morbidity and mortality. Future physical activity guidelines should 
incorporate specific recommendations on strategies to reduce sedentary behavior. 
Habitual physical activity and exercise training are powerful strategies to reduce the 
risk for adverse cardiovascular outcomes and mortality in a dose dependent way. High 
intensity exercise produces larger health benefits compared to moderate intensity 
exercise. Personalized exercise programs and wireless devices with real-time 
feedback may help individuals meet the international guidelines for physical activity. 
Currently, there is no strong evidence that supports the ‘too much exercise hypothesis’. 
Individuals performing exercise at a multiple of the recommended dose live longer and 
have a comparable risk for cardiovascular morbidity and mortality as moderately active 
peers.  
 
  
Key points 
 Prolonged sitting is highly prevalent in the general population and increases the 
risk for cardiovascular mortality. Breaking-up of prolonged sitting time or 
replacement of sitting time by (light) physical activity can effectively reduce the 
detrimental effects of sitting.  
 A curvilinear dose-response relationship between exercise and cardiovascular 
health is found. Low doses of exercise improve health, but higher doses give 
larger benefits. Also, high-intensity activities induce larger risk reductions 
compared to moderate-intensity activities of a similar volume.  
 Exercise-induced cardiac remodeling of all cardiac chambers is present in 
athletes. Acute exercise can lead to transient cardiac dysfunction and cardiac 
biomarker release. Chronic exercise may increase the risk for atrial fibrillation. 
Nevertheless, there is strong evidence that athletes live longer compared to 
individuals from the general population.  
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